Press

If you are a member of the media and need help with a story or want to arrange an interview with an AABB spokesperson, please contact AABB’s Public Relations Department by emailing publicrelations@aabb.org or dialing +1.301.215.6526.

2024 Press Releases

AABB Publishes Updated Fact Sheets Highlighting Emerging Threats to Blood Safety

02/28/2024

AABB is pleased to announce the publication of an updated and comprehensive library of Emerging Infectious Disease (EID) Fact Sheets in a digital version of Transfusion.

2023 Press Releases

Blood Community Unites to Recognize Donors Ahead of National Blood Donor Month in January

12/20/2023

AABB, America’s Blood Centers (ABC) and the American Red Cross (ARC) are uniting to express gratitude to the roughly 7 million people across the United States who donate blood as National Blood Donor Month approaches in January.
New Red Blood Cell Transfusion Guidelines Recommend an Individualized Approach

10/12/2023

For most patients requiring red blood cell transfusions, a restrictive transfusion strategy is often optimal, according to new guidelines developed by an international panel of experts and published in JAMA this week.
AABB Provides Complimentary Resources for Blood Community to Aid in Implementation of Individual Donor Assessments

07/17/2023

AABB is pleased to offer a resource library with training materials and job aids for U.S. blood collection facilities as they prepare for the implementation of IDA protocols.
Jeff Wren to Join AABB as Vice President, Biotherapies

07/12/2023

AABB announced today that Jeff Wren, MBA, will join the Association as vice president, biotherapies. He will begin his new role on July 17.
AABB Applauds FDA’s Final Guidance Recommending Individual Donor Assessment for Blood Donor Eligibility

05/11/2023

AABB applauds the Food and Drug Administration for issuing a final guidance that recommends determining blood donor eligibility based on an individual assessment.
AABB Applauds FDA’s Recommendations to Implement Individual Risk Assessment for Blood Donors

01/31/2023

AABB applauds the FDA for its recent draft guidance recommending blood donor eligibility be based on an individual’s behavior and risks, regardless of the donor’s gender or sexual orientation.
AABB Introduces New Biotherapies Corporate Membership Program

01/12/2023

AABB is proud to introduce the AABB Biotherapies Corporate Membership Program, an initiative designed to ease challenges that biotherapies companies face, including workforce development, quality systems control and regulatory support.
Blood Community Unites to Thank America’s Donors this National Blood Donor Month

01/04/2023

AABB, America’s Blood Centers (ABC) and the American Red Cross are joining together to thank America’s more than 7 million blood donors as they mark National Blood Donor Month.

2022 Press Releases

AABB Congratulates Inaugural CABP Cohort

12/19/2022

Biotherapies professionals achieving this distinction have demonstrated their qualifications by meeting pre-requisites and passing an exam that covered seven domains of the field.
As Hurricane Ian Makes Landfall, Individuals in Unaffected Areas Urged to Donate Blood

09/28/2022

As Hurricane Ian reaches Florida, the AABB Interorganizational Task Force on Domestic Disasters and Acts of Terrorism strongly urges eligible individuals in unaffected areas throughout the U.S. to schedule a donation appointment as soon as possible.
Fresenius Kabi and AABB Celebrate 17th Annual Blood Collectors Week from Sept. 4-10

09/04/2022

Honoring blood collection professionals and their lifesaving impact on patient care
AABB Introduces New Biotherapies Credentialing Program

08/19/2022

The Association for the Advancement of Blood & Biotherapies (AABB) recently introduced the AABB Certified Advanced Biotherapies Professional (CABP) credentialing program. This is the first and only certification for biotherapies professionals.
AABB Appoints Sharon Carayiannis as Vice President, Science and Practice

03/18/2022

AABB is pleased to announce the appointment of Sharon Carayiannis, BSMT(ASCP)HP, as its vice president for Science and Practice. Carayiannis has served AABB in this role on an interim basis since October 2021.

Press

2024 Press Releases

2023 Press Releases

2022 Press Releases

2021 Press Releases

2020 Press Releases

2019 Press Releases

2018 Press Releases